Key facts
- It has raised $1.6M; the latest was Early Stage VC ($1.6M) in Jul 2025.
- Notable investors include AMC Ventures Holding, CbusineZ, LifeSciences@Work, Neuromotion Ventures, Utrechtinc — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Trianect
- ·The full record, as it builds
Funding rounds
No funding rounds for Trianect are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Trianect
Developer of medical equipment intended to detect treatable stroke patients in the ambulance. The company's device combines brain activity measurement and artificial intelligence to detect treatable strokes, enabling healthcare professionals to save time and bring patients directly to the best treatment.
- Sector
- Healthcare
- HQ
- Utrecht, Netherlands
- Founded
- 2021
- Employees
- 1
- Website
- trianect.com/
- Ownership
- Privately Held (backing)
Trianect doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Trianect shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Trianect in its N-PORT filings yet. We sweep new filings monthly.